RWE.DE vs. NOVO-B.CO
RWE.DE (RWE AG) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. RWE.DE operates in Utilities - Diversified (Utilities), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, RWE.DE returned 19.88%/yr vs 17.26%/yr for NOVO-B.CO. At a 0.17 correlation, their price movements are largely independent.
Performance
RWE.DE vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
RWE.DE is traded in EUR, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, RWE.DE achieves a 29.46% return, which is significantly higher than NOVO-B.CO's -8.77% return. Over the past 10 years, RWE.DE has outperformed NOVO-B.CO with an annualized return of 19.88%, while NOVO-B.CO has yielded a comparatively lower 17.26% annualized return.
RWE.DE
- 1D
- -0.07%
- 1M
- 1.70%
- YTD
- 29.46%
- 6M
- 35.20%
- 1Y
- 64.64%
- 3Y*
- 16.35%
- 5Y*
- 16.17%
- 10Y*
- 19.88%
NOVO-B.CO
- 1D
- 1.61%
- 1M
- -4.08%
- YTD
- -8.77%
- 6M
- -7.60%
- 1Y
- -41.92%
- 3Y*
- 4.37%
- 5Y*
- 20.51%
- 10Y*
- 17.26%
RWE.DE vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RWE.DE RWE AG | 29.46% | 62.21% | -27.81% | 1.17% | 19.08% | 6.06% | 29.69% | 48.79% | 14.26% | 43.82% |
NOVO-B.CO Novo Nordisk A/S | -8.77% | -46.44% | -9.91% | 205.51% | 31.09% | 79.61% | 15.78% | 35.77% | -6.27% | 39.30% |
Correlation
The correlation between RWE.DE and NOVO-B.CO is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.17 |
The correlation between RWE.DE and NOVO-B.CO shifts across timeframes, from -0.04 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RWE.DE vs. NOVO-B.CO — Risk / Return Rank
RWE.DE
NOVO-B.CO
RWE.DE vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for RWE AG (RWE.DE) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RWE.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.48 | ||
| Sortino ratioReturn per unit of downside risk | +4.53 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 0.87 | +0.58 |
| Calmar ratioReturn relative to maximum drawdown | 6.37 | -0.78 | +7.15 |
| Martin ratioReturn relative to average drawdown | 15.02 | -1.15 | +16.17 |
Loading charts...
Drawdowns
RWE.DE vs. NOVO-B.CO - Drawdown Comparison
The maximum RWE.DE drawdown since its inception was -85.39%, which is greater than NOVO-B.CO's maximum drawdown of -76.81%. Use the drawdown chart below to compare losses from any high point for RWE.DE and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| RWE.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.39% | -76.81% | -8.58% |
Max Drawdown (1Y)Largest decline over 1 year | -10.37% | -54.72% | +44.35% |
Max Drawdown (3Y)Largest decline over 3 years | -30.49% | -76.81% | +46.32% |
Max Drawdown (5Y)Largest decline over 5 years | -32.19% | -76.81% | +44.62% |
Max Drawdown (10Y)Largest decline over 10 years | -39.02% | -76.81% | +37.79% |
Current DrawdownCurrent decline from peak | -5.46% | -70.26% | +64.80% |
Average DrawdownAverage peak-to-trough decline | -45.33% | -11.90% | -33.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.40% | 37.20% | -32.80% |
Volatility
RWE.DE vs. NOVO-B.CO - Volatility Comparison
The current volatility for RWE AG (RWE.DE) is 7.73%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 11.47%. This indicates that RWE.DE experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RWE.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.73% | 11.47% | -3.74% |
Volatility (6M)Calculated over the trailing 6-month period | 18.70% | 39.57% | -20.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.54% | 54.44% | -29.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.61% | 58.61% | -33.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.31% | 45.19% | -16.88% |
Dividends
RWE.DE vs. NOVO-B.CO - Dividend Comparison
RWE.DE's dividend yield for the trailing twelve months is around 2.09%, less than NOVO-B.CO's 4.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
RWE.DE RWE AG | 2.09% | 2.43% | 3.47% | 2.19% | 2.16% | 2.38% | 2.31% | 2.56% | 2.64% | 0.00% | 1.10% | 8.54% |
Financials
RWE.DE vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between RWE AG and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RWE.DE and NOVO-B.CO have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for RWE.DE and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer